RUBIN PAUL D 4
4 · BioAge Labs, Inc. · Filed Dec 11, 2025
Insider Transaction Report
Form 4
RUBIN PAUL D
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$6.57/sh+18,000$118,260→ 18,000 total - Sale
Common Stock
2025-12-09$12.00/sh−18,000$216,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-09−18,000→ 9,383 totalExercise: $6.57Exp: 2032-05-28→ Common Stock (18,000 underlying)
Footnotes (2)
- [F1]The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.
- [F2]The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.